MYO
Price
$6.10
Change
-$0.05 (-0.81%)
Updated
Jan 17 closing price
Capitalization
93.15M
46 days until earnings call
RDNT
Price
$59.86
Change
-$1.02 (-1.68%)
Updated
Jan 17 closing price
Capitalization
3.55B
44 days until earnings call
Ad is loading...

MYO vs RDNT

Header iconMYO vs RDNT Comparison
Open Charts MYO vs RDNTBanner chart's image
Myomo
Price$6.10
Change-$0.05 (-0.81%)
Volume$303.55K
Capitalization93.15M
RadNet
Price$59.86
Change-$1.02 (-1.68%)
Volume$827.74K
Capitalization3.55B
MYO vs RDNT Comparison Chart
Loading...
MYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
MYO vs. RDNT commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is MYO is a Hold and RDNT is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 19, 2025
Stock price -- (MYO: $6.10 vs. RDNT: $59.86)
Brand notoriety: MYO and RDNT are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: MYO: 84% vs. RDNT: 149%
Market capitalization -- MYO: $93.15M vs. RDNT: $3.55B
MYO [@Medical Specialties] is valued at $93.15M. RDNT’s [@Medical Specialties] market capitalization is $3.55B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.11B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

MYO’s FA Score shows that 0 FA rating(s) are green whileRDNT’s FA Score has 1 green FA rating(s).

  • MYO’s FA Score: 0 green, 5 red.
  • RDNT’s FA Score: 1 green, 4 red.
According to our system of comparison, both MYO and RDNT are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

MYO’s TA Score shows that 4 TA indicator(s) are bullish while RDNT’s TA Score has 2 bullish TA indicator(s).

  • MYO’s TA Score: 4 bullish, 3 bearish.
  • RDNT’s TA Score: 2 bullish, 5 bearish.
According to our system of comparison, MYO is a better buy in the short-term than RDNT.

Price Growth

MYO (@Medical Specialties) experienced а -6.30% price change this week, while RDNT (@Medical Specialties) price change was -12.97% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was +0.97%. For the same industry, the average monthly price growth was +5.53%, and the average quarterly price growth was +1.10%.

Reported Earning Dates

MYO is expected to report earnings on May 07, 2025.

RDNT is expected to report earnings on May 12, 2025.

Industries' Descriptions

@Medical Specialties (+0.97% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RDNT($3.55B) has a higher market cap than MYO($93.2M). MYO YTD gains are higher at: -5.280 vs. RDNT (-14.290). RDNT has higher annual earnings (EBITDA): 293M vs. MYO (-7.71M). RDNT has more cash in the bank: 343M vs. MYO (8.87M). MYO has less debt than RDNT: MYO (601K) vs RDNT (1.49B). RDNT has higher revenues than MYO: RDNT (1.62B) vs MYO (19.2M).
MYORDNTMYO / RDNT
Capitalization93.2M3.55B3%
EBITDA-7.71M293M-3%
Gain YTD-5.280-14.29037%
P/E RatioN/A962.00-
Revenue19.2M1.62B1%
Total Cash8.87M343M3%
Total Debt601K1.49B0%
FUNDAMENTALS RATINGS
MYO vs RDNT: Fundamental Ratings
MYO
RDNT
OUTLOOK RATING
1..100
8959
VALUATION
overvalued / fair valued / undervalued
1..100
58
Fair valued
93
Overvalued
PROFIT vs RISK RATING
1..100
10020
SMR RATING
1..100
9890
PRICE GROWTH RATING
1..100
3858
P/E GROWTH RATING
1..100
10074
SEASONALITY SCORE
1..100
50n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

MYO's Valuation (58) in the Medical Distributors industry is somewhat better than the same rating for RDNT (93) in the Medical Or Nursing Services industry. This means that MYO’s stock grew somewhat faster than RDNT’s over the last 12 months.

RDNT's Profit vs Risk Rating (20) in the Medical Or Nursing Services industry is significantly better than the same rating for MYO (100) in the Medical Distributors industry. This means that RDNT’s stock grew significantly faster than MYO’s over the last 12 months.

RDNT's SMR Rating (90) in the Medical Or Nursing Services industry is in the same range as MYO (98) in the Medical Distributors industry. This means that RDNT’s stock grew similarly to MYO’s over the last 12 months.

MYO's Price Growth Rating (38) in the Medical Distributors industry is in the same range as RDNT (58) in the Medical Or Nursing Services industry. This means that MYO’s stock grew similarly to RDNT’s over the last 12 months.

RDNT's P/E Growth Rating (74) in the Medical Or Nursing Services industry is in the same range as MYO (100) in the Medical Distributors industry. This means that RDNT’s stock grew similarly to MYO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
MYORDNT
RSI
ODDS (%)
Bearish Trend 12 days ago
84%
Bullish Trend 12 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 12 days ago
88%
Bearish Trend 12 days ago
72%
Momentum
ODDS (%)
Bullish Trend 12 days ago
85%
Bearish Trend 12 days ago
73%
MACD
ODDS (%)
Bullish Trend 12 days ago
81%
N/A
TrendWeek
ODDS (%)
Bullish Trend 12 days ago
82%
Bullish Trend 12 days ago
83%
TrendMonth
ODDS (%)
Bullish Trend 12 days ago
83%
Bearish Trend 12 days ago
70%
Advances
ODDS (%)
Bullish Trend 13 days ago
79%
Bullish Trend 14 days ago
79%
Declines
ODDS (%)
Bearish Trend 21 days ago
88%
Bearish Trend 12 days ago
71%
BollingerBands
ODDS (%)
N/A
N/A
Aroon
ODDS (%)
Bullish Trend 12 days ago
90%
Bearish Trend 12 days ago
75%
View a ticker or compare two or three
Ad is loading...
MYO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RDNT
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WMLLF0.04N/A
+1.69%
Wealth Minerals Ltd.
ENGIY16.590.17
+1.04%
ENGIE SA
GNGBY17.210.04
+0.23%
Getinge AB
NURAF29.05-0.36
-1.22%
Nomura Research Institute Ltd.
LILIF0.07N/A
-5.08%
Argentina Lithium & Energy Corp

MYO and

Correlation & Price change

A.I.dvisor tells us that MYO and CTKB have been poorly correlated (+28% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that MYO and CTKB's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To MYO
1D Price
Change %
MYO100%
-0.81%
CTKB - MYO
28%
Poorly correlated
-0.55%
MXCT - MYO
27%
Poorly correlated
+4.00%
RDNT - MYO
27%
Poorly correlated
-1.68%
PLSE - MYO
26%
Poorly correlated
-0.17%
CERS - MYO
26%
Poorly correlated
-1.65%
More

RDNT and

Correlation & Price change

A.I.dvisor indicates that over the last year, RDNT has been loosely correlated with BLFS. These tickers have moved in lockstep 43% of the time. This A.I.-generated data suggests there is some statistical probability that if RDNT jumps, then BLFS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RDNT
1D Price
Change %
RDNT100%
-1.68%
BLFS - RDNT
43%
Loosely correlated
-1.17%
NEO - RDNT
40%
Loosely correlated
+1.65%
BVS - RDNT
39%
Loosely correlated
-0.69%
QTRX - RDNT
38%
Loosely correlated
+0.57%
NTRA - RDNT
38%
Loosely correlated
-6.02%
More